BECN1 and lip and oral cavity carcinoma: Moreover, the levels of phosphorylated RelA/p65 at Ser536 (RelA S536-P), a primary active component in the canonical NF-κB pathway, and BECN1 expression were elevated in LPLI-treated oral cancer cells.